about
The Apoe(-/-) mouse model: a suitable model to study cardiovascular and respiratory diseases in the context of cigarette smoke exposure and harm reductionTANGO1 and Mia2/cTAGE5 (TALI) cooperate to export bulky pre-chylomicrons/VLDLs from the endoplasmic reticulumApolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion.Control of very low-density lipoprotein secretion by N-ethylmaleimide-sensitive factor and miR-33Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering.Hepatocyte-Specific Depletion of UBXD8 Induces Periportal Steatosis in Mice Fed a High-Fat DietMature VLDL triggers the biogenesis of a distinct vesicle from the trans-Golgi network for its export to the plasma membrane.On the function and homeostasis of PCSK9: reciprocal interaction with LDLR and additional lipid effects.Human plasma protein N-glycosylationEctopic lipid storage and insulin resistance: a harmful relationship.Hyperlipoproteinemia type 3: the forgotten phenotype.Non-alcoholic fatty liver disease as a consequence of autonomic imbalance and circadian desynchronization.Regression of Atherosclerosis: The Journey From the Liver to the Plaque and BackTargeting microsomal triglyceride transfer protein and lipoprotein assembly to treat homozygous familial hypercholesterolemia.Membrane Protein Quantity Control at the Endoplasmic Reticulum.Shunts, channels and lipoprotein endosomal traffic: a new model of cholesterol homeostasis in the hepatocyte.Gingival crevicular fluid and its immune mediators in the proteomic era.Can modulators of apolipoproteinB biogenesis serve as an alternate target for cholesterol-lowering drugs?
P2860
Q26747185-7AAAA866-561F-4C23-AF85-83DDC3C0F079Q28118978-89DB2CFE-CA52-430D-8791-5206CE3B1096Q33858526-7903703B-1956-4BA9-825E-FA08D4CF8B65Q33940346-547A3445-B1B3-4198-B53B-DAF09AFF8423Q34536594-547A7239-95AB-4F99-8C81-544CD15811F7Q35602046-8DD12E76-D505-4820-AC2B-A8EDECCC309CQ35670409-6F0EC491-99D8-4103-B0B9-984EC5E756EBQ36035643-9A8E9C21-AF1F-45F8-B441-21A19080DC02Q36963945-D2A6661A-0EDD-48AA-937D-705591D8966BQ38095619-6B2D7D2E-7BD3-4922-B2DD-EF78BB5019BEQ38235600-4CC6E30B-5011-46B7-83E9-071B26F6407FQ38555120-F6516E37-5405-4495-ABC2-58138D09CDEEQ38560870-D44161F0-CC91-4BD3-AD9C-F3CE5864C6D4Q38969073-C5DF77F1-CF9B-4710-9AEF-546389E9DD0BQ38981333-2FB73694-5448-453E-B768-C017D896A2A7Q41851007-046D2C2B-2659-449A-ADEB-F4A4A89D928EQ47343603-98F17D7D-036E-4733-B068-7201A0CD7F07Q52600967-E6BDC8FB-8E9C-4FF4-AB46-0149BA0CC8B9
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Apolipoprotein B secretory regulation by degradation
@ast
Apolipoprotein B secretory regulation by degradation
@en
Apolipoprotein B secretory regulation by degradation
@nl
type
label
Apolipoprotein B secretory regulation by degradation
@ast
Apolipoprotein B secretory regulation by degradation
@en
Apolipoprotein B secretory regulation by degradation
@nl
prefLabel
Apolipoprotein B secretory regulation by degradation
@ast
Apolipoprotein B secretory regulation by degradation
@en
Apolipoprotein B secretory regulation by degradation
@nl
P3181
P1476
Apolipoprotein B secretory regulation by degradation
@en
P2093
S.-O. Olofsson
P304
P3181
P356
10.1161/ATVBAHA.112.251116
P407
P577
2012-06-01T00:00:00Z